Cardiovascular morbidity and mortality after kidney transplantation.
about
Patterns of Care and Outcomes in Cardiovascular Disease After Kidney Transplantation in the United States.The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.Discontinuation of steroids in ABO-incompatible renal transplantation.Renalase Assessment With Regard to Kidney Function, Lipid Disturbances, and Endothelial Dysfunction Parameters in Stable Renal Transplant Recipients.Mesenchymal stromal cells in renal transplantation: opportunities and challenges.Cardiovascular disease: Risk factors and applicability of a risk model in a Greek cohort of renal transplant recipients.Noteworthy Literature Published in 2016 for Abdominal Organ Transplant Anesthesiologists.Negative Cardiovascular Consequences of Small Molecule Immunosuppressants.Oral Health and Mortality in Patients With Chronic Kidney Disease.C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.Iron deficiency, anemia, and mortality in renal transplant recipients.Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 Study.Diabetic Nephropathy: a Tangled Web to Unweave.The effect of aspirin on kidney allograft outcomes; a short review to current studies.Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis.Clinical Features of Kidney Transplant Recipients Admitted to the Intensive Care Unit.Chronic kidney disease, kidney transplantation and oxidative stress: a new look to successful kidney transplantation.Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients.Autonomic modulation analysis in active and sedentary kidney transplanted recipients.Impact of the pretransplant dialysis modality on kidney transplantation outcomes: a nationwide cohort study.Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.
P2860
Q37722898-055EB198-4E2B-41C5-8A60-86C4B4823958Q38585232-04B88FB5-D262-45BB-9FCC-D42A1C9C5913Q38680131-712A7B6C-06D0-4F0B-B43C-1D096797A68EQ38724681-AF201673-1B65-40E8-BC24-EBFE7170E3A0Q38725481-956F1A51-1DE6-4ED2-BF53-48EA7B6073B1Q38915837-E716D977-0665-4562-A54A-EC96DA8C89FBQ39096764-1EAAC93B-2131-4680-9CF2-EA1F96E022C1Q39312540-EAF91AC1-B0F0-461D-B5D6-7C9D186FA9A2Q39491418-CFAA6F38-2FA4-4B59-9C5A-81F3C44B815BQ40095461-EA4F6D49-F2B0-4460-8B55-F8F8FE697937Q40513541-7AA15E8C-6E4E-4425-8306-6D164D9C0CF2Q40979801-3BADD0AE-5F54-4A28-86F6-5131C879811BQ41993558-F976BB9B-27AB-4B0D-8C08-6EA323BF4315Q42361916-EB72DD76-C3C6-444E-A1E0-B0312D354271Q47107775-CD91288F-DB62-45F2-A2F8-DB620F4ACF48Q47119851-C1F6ACF5-FB1A-42C9-A79F-F08FD1FEBE29Q47282123-2846571D-6760-4821-9D82-26BF2C7239EAQ49190327-E7187881-ABF7-44FF-9679-F83D55775704Q50097447-1041D418-9903-44C9-8A85-EBFB41E403A4Q53380971-362CEC60-53A4-4CFC-8D58-1635EB5A5DE9Q55205697-8B8409F2-0089-4C4E-B917-3993D604D23AQ55450034-C3BD04A8-CF3B-4D6B-BEB7-E08674AFB666
P2860
Cardiovascular morbidity and mortality after kidney transplantation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cardiovascular morbidity and mortality after kidney transplantation.
@en
type
label
Cardiovascular morbidity and mortality after kidney transplantation.
@en
prefLabel
Cardiovascular morbidity and mortality after kidney transplantation.
@en
P2860
P356
P1476
Cardiovascular morbidity and mortality after kidney transplantation.
@en
P2093
Sokratis Stoumpos
P2860
P356
10.1111/TRI.12413
P577
2014-08-20T00:00:00Z